Search hospitals > Colorado > Golden
SCL Health Cancer Centers of Colorado - Lutheran Medical Center
Claim this profileGolden, Colorado 80401
Conducts research for Breast Cancer
Conducts research for Skin Cancer
Conducts research for Colon Cancer
Conducts research for Breast cancer
Conducts research for Parotid Gland Cancer
14 reported clinical trials
5 medical researchers
Summary
SCL Health Cancer Centers of Colorado - Lutheran Medical Center is a medical facility located in Golden, Colorado. This center is recognized for care of Breast Cancer, Skin Cancer, Colon Cancer, Breast cancer, Parotid Gland Cancer and other specialties. SCL Health Cancer Centers of Colorado - Lutheran Medical Center is involved with conducting 14 clinical trials across 43 conditions. There are 5 research doctors associated with this hospital, such as Marwan Massouh, Karng S. Log, Ian Gallaher, and Julie A. Carlson.Area of expertise
1Breast Cancer
ER positive
HER2 positive
ER negative
2Skin Cancer
p16 positive
p16 negative
Stage IV
Top PIs
Marwan MassouhSaint James Community Hospital and Cancer Treatment Center8 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
11 reported clinical trials
35 drugs studied
Karng S. LogLutheran Hospital - Cancer Centers of Colorado2 years of reported clinical research
Studies Small Cell Lung Cancer
Studies Colon Cancer
10 reported clinical trials
32 drugs studied
Ian GallaherSaint James Community Hospital and Cancer Treatment Center7 years of reported clinical research
Studies Prostate Cancer
Studies Small Cell Lung Cancer
5 reported clinical trials
18 drugs studied
Julie A. CarlsonSCL Health Cancer Centers of Colorado - Lutheran Medical Center7 years of reported clinical research
Studies Breast Cancer
1 reported clinical trial
2 drugs studied
Clinical Trials running at SCL Health Cancer Centers of Colorado - Lutheran Medical Center
Breast Cancer
Lung Cancer
Esophageal cancer
Breast cancer
ALK Gene Rearrangement
Esophageal Adenocarcinoma
Gastric cancer
Gastroesophageal Junction Adenocarcinoma
Esophageal Cancer
Stomach Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at SCL Health Cancer Centers of Colorado - Lutheran Medical Center?
SCL Health Cancer Centers of Colorado - Lutheran Medical Center is a medical facility located in Golden, Colorado. This center is recognized for care of Breast Cancer, Skin Cancer, Colon Cancer, Breast cancer, Parotid Gland Cancer and other specialties. SCL Health Cancer Centers of Colorado - Lutheran Medical Center is involved with conducting 14 clinical trials across 43 conditions. There are 5 research doctors associated with this hospital, such as Marwan Massouh, Karng S. Log, Ian Gallaher, and Julie A. Carlson.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.